DRUG COMPANIES

Foreign investment funds have been showing a growing interest in Greek pharmaceutical exporters in the last year. According to sources from the Panhellenic Association of Pharmaceutical Industry (PEF), the exporters produce drugs at a much lower cost than European peers and can sell their products abroad at a price up to three times higher than what they can get in Greece.